To register your interest and determine whether you may be eligible to participate in one or more of the Australian MS Clinical Trial Platform (AMSCTP) trials, you are invited to complete an eligibility survey within MS Trial Screen.
Features of MS Trial Screen:
MS Trial Screen currently supports three AMSCTP clinical trials – PLATYPUS, STOP-MS and FIRMS EBV. To read more about these trials, please scroll down. To access MS Trial screen and complete the eligibly survey now
MS Trial Screen was developed and is managed by the Menzies Institute for Medical Research at the University of Tasmania and has been approved by the University of Tasmania Human Research Ethics Committee (H31237). It is funded by MS Australia to help people navigate MS clinical trials in Australia.
To access MS Trial Screen and complete the eligibility survey: